Slideshow

Adjunctive Cannabidiol Therapy in Schizophrenia

Author(s):

Brian Miller, MD, PhD, MPH

New research looks at the effects of CBD on positive and negative psychotic symptoms, cognitive performance, level of functioning, and the treating psychiatrist’s overall clinical impression.

Related Videos
Tierney/AdobeStock
Julyuela/AdobeStock
schizophrenia
2025
Erin Crown, PA-C, CAQ-Psychiatry, and John M. Kane, MD, experts on schizophrenia
nicotine use
brain schizophrenia
schizophrenia
schizophrenia
exciting, brain
Related Content
catatonia
March 12th 2025

Managing Catatonia: A Case Report From Rural South Africa

Grace Lehnerdt, MD
Treating ‘Morally Objectionable’ Patients
September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD
postpartum
March 7th 2025

Tragic or Treated: Why We Cannot Miss Postpartum Psychosis

Meghan Cliffel Susan Hatters Friedman, MD, MSt, DFAPA
More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle
May 11th 2021

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

Anita H. Clayton, MD
Stephen McLeod-Bryant, MD
February 28th 2025

Learning How to Actively Listen: In Conversation With Stephen McLeod-Bryant, MD

Leah Kuntz Stephen McLeod-Bryant, MD
FDA Officially Removes REMS Requirement for Clozapine
February 25th 2025

FDA Officially Removes REMS Requirement for Clozapine

Heidi Anne Duerr, MPH
© 2025 MJH Life Sciences

All rights reserved.